Clinical Impact of 16S rDNA PCR
- Conditions
- Bacterial Infections
- Registration Number
- NCT03915275
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
The main objective of this study is to evaluate the impact of a positive 16S rDNA PCR in various sites on patient's management.
The secondary objectives of the protocol are:
* to evaluate bacterial identification performance
* to evaluate the effect of previous antibiotic therapy
* to analyze the management of discordant results between 16S PCR and culture identification
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Patients that had a 16S rDNA PCR positive result in Strasbourg University Hospital laboratory from 2014 to 2018
- Patients consent for this analysis of their past medical history
- Legal guardians consent for the analysis of their children's medical history
Exclusion Criteria
- Patients who express opposition for this study
- Incomplete clinical record
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Study of the modification of the care of the patients by the use of the 16S PCR The period from Junuary 1st, 2014 to Dcember 31, 2018 will be examined
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service de Maladies Infectieuses et Tropicales
🇫🇷Strasbourg, France